Satisfaction with Information Provision and Health-related Quality of Life in Basal and Squamous Cell Carcinoma Patients: A Cross-sectional Population-based Study by Waalboer-Spuij, R. (Rick) et al.
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
SHORT COMMUNICATION
Acta Derm Venereol 2019; 99: 933–934
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Journal Compilation © 2019 Acta Dermato-Venereologica.
doi: 10.2340/00015555-3226
933
The incidence of keratinocytic carcinomas (KC) (basal 
cell carcinoma (BCC) and squamous cell carcinoma 
(SCC)) is high and further increasing. It is important to 
identify patients with high disease burden (1, 2). The Basal 
and Squamous Cell Carcinoma Quality of Life (BaSQoL) 
questionnaire was developed to measure disease specific 
Health-Related Quality of Life (HRQoL) (3). In other can-
cer patients it was shown that better information provision 
is associated with better HRQoL (4). Information provi-
sion is an important aspect of supportive care: increasing 
knowledge about disease and treatment leads to better 
illness perception, which could lead to a better HRQoL 
(5). This relation has not been described in KC patients, 
and may differ from other cancers, due to low mortality 
and low impact treatment. This study aims to assess the 
satisfaction with received information and the association 
with HRQoL in population-based sample of KC patients in 
the Netherlands. We hypothesized that, patients satisfied 
with received information report a better HRQoL. 
METHODS
A cross-sectional study was performed among 1,173 patients, selec-
ted from the Southern region of the population-based Netherlands 
Cancer Registry (NCR). Data were collected during the validation 
of the BaSQoL (3, 6). Socio-demographic data were collected and 
disease specific data were gathered from the NCR. Unfortunately, 
there were no data on the provided information available.
Satisfaction with the information provision was measured with 
the European Organisation for Research and Treatment of Cancer 
Quality of Life Questionnaire INFO25 (EORTC QLQ-INFO25) 
(7). For this study, the 4-point Likert scale of the item ‘satisfaction 
with information provision’ was dichotomized into satisfied (‘quite 
a bit’ – ‘very much’) and dissatisfied (‘not at all’ – ‘a little’). Cancer-
specific quality of life was measured by the EORTC QLQ-Core 
30 (EORTC QLQ-C30) (8). The disease-specific BaSQoL has 5 
subscales (3). Higher scores implicate a higher HRQoL impact. The 
self-reported comorbidity questionnaire measured comorbidity (9).
Statistical analyses
Mean values were compared with independent sample t-tests bet-
ween patients who were satisfied and dissatisfied with information. 
Bar charts display the BaSQoL and EORTC QLQ-C30 subscales, 
stratified by satisfaction with information provision. The associa-
tion between HRQoL (outcome) and satisfaction with information 
(covariate) was assessed with multivariable linear regression ana-
lysis. Other a priori selected covariates included: age, time since 
diagnosis, sex, education, occupation, partnership, comorbidity, 
and type of tumour. Multiple imputations (n = 25) were used to ac-
count for the missing data (all covariates and outcomes included). 
Multiple linear regression assumptions were met. 
p-values < 0.05 (two-sided) from regression models were con-
sidered statistically significant. All other p-values were corrected 
(Benjamini-Hochberg procedure) and considered statistically 
significant if p < 0.033 (two-sided) (10). Analyses were performed 
in SPSS, Version 21.0 (Armonk, New York: IBM Corporation).
RESULTS
Of the 1,173 patients, 721 (61%) completed the ques-
tionnaire. Patient and tumour characteristics are shown 
in Table SI1. There was no difference in satisfaction 
with information in tumour type (BCC vs SCC) or 
BCC subtype, facial tumour, not having a partner and 
having more comorbidities (Table SI1). Thirty-seven 
percent (84/225) dissatisfied and 7% (28/416) satisfied 
patients indicated that they had wanted more informa-
tion about skin cancer in general, causes, treatment, 
follow-up and how to recognize new lesions. Three 
percent (n = 24) wanted less information. The 
information received was considered helpful 
in 68% (n = 417). HRQoL was statistically 
significantly lower among patients who were 
dissatisfied with information provision (Fig. 1). 
Satisfaction with information provision was 
associated with behaviour, diagnosis and treat-
ment, worries and appearance BaSQoL subscales 
with negative beta values (–0.3 to –0.1), indica-
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Fig. 1. Mean with standard error. Basal and squamous cell 
carcinoma quality of life (a) and European Organisation for Research 
and Treatment of Cancer Quality of Life Questionnaire-C30 subscale 
scores and satisfaction with information provision (b).
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ting satisfied patients had  lower BaSQoL subscale scores, 
thus lower HRQoL impact (Table SII1).
Other factors associated with worse HRQoL were 
younger age (all BaSQoL subscales), less time since di-
agnosis (diagnosis and treatment, worries and appearance, 
indicating higher HRQoL impact with more recent  diag-
nosis) and being female (diagnosis & treatment, worries 
and other people). Facial tumour location was associated 
with higher HRQoL impact in behaviour, diagnosis and 
treatment and appearance subscales. SCC led to higher 
scores than BCC in worries and other people subscales.
DISCUSSION
Patients dissatisfied with information provision had sta-
tistically significantly higher impact on 4 of 5 BaSQoL 
subscales and all EORTC QLQ-C30 subscales. There are 
two possible explanations. First, patients dissatisfied with 
provided information may not have sufficient knowledge 
about disease and treatment and therefore have inadequate 
illness perception causing more HRQoL impact. Second, 
patients reporting negative impact of their disease on 
HRQoL are generally more dissatisfied with care, thus also 
with information provision. Satisfaction with informa-
tion and HRQoL were assessed at a single time point, so 
differentiation is not possible. Worse HRQoL (BaSQoL) 
was found in younger patients, similar to the findings in 
another study in cancer patients (11).
In contrast to our hypothesis, impact on appearance 
subscale was not different between sexes, whilst females ex-
perienced larger impact on diagnosis and treatment, worries 
and other people subscales. To improve HRQoL impact in 
KC patients, the BaSQoL could be used to identify patients 
with higher impact and provide supportive care accordingly. 
This study also showed that 1/3 of Dutch KC patients 
was dissatisfied with the received information. Dissatis-
fied patients showed lower scores on all subscales of the 
provided information (EORTC INFO-25) compared to 
the satisfied patients. Comparable results were found in 
other cancers (5). 
Patients dissatisfied with provided information, would 
like more information. This is desirable, because informa-
tion provision helps understanding and coping with the 
disease and treatment choice (4). Factors associated with 
dissatisfaction with provided information were younger 
age, facial tumour, not having a partner and more comorbi-
dity. Similar to our study, unmarried status was associated 
with patients’ perception of inadequate information provi-
sion. In contrast to our study, lower income and education, 
female sex, and type of cancer with good prognosis were 
associated with dissatisfaction with information (12).
Strengths include the use of validated questionnaires 
and the generalizability. A limitation was the cross-sec-
tional design and therefore inability to determine if dis-
satisfaction with information provision leads to decreased 
HRQoL or vice versa. 
Providing satisfactory information to KC patients should 
be improved, especially in younger patients, patients with 
a facial tumour, those without partner and with more co-
morbidity. Dissatisfaction with provided information is as-
sociated with HRQoL impact. Females and younger patients 
experienced a higher BaSQoL impact.These subgroups 
require more supportive care, but further research is neces-
sary to identify these patients based on BaSQoL scores.
ACKNOWLEDGEMENTS
Members of the BaSQoL Group: M.J. Aarts, M.T. Bastiaens, O. 
Husson, B.A. Jagtman, F.H.J. Koedijk, D.I.M. Kuijpers, H.C.J. 
Liberton, J.M. Mommers, S. Oerlemans, K.P. de Roos, M.W.H. 
Timmermans, E. de Vries, L.J.M.T. Weppner-Parren.
This study was approved by the ethics committee of the Erasmus 
MC (Reference MEC-2013-420). This study was financially sup-
ported by Roche, Leo Pharma and Galderma.
The authors have no conflict of interest to declare.
REFERENCES
1. Flohil SC, de Vries E, Neumann HA, Coebergh JW, Nijsten T. Inci-
dence, prevalence and future trends of primary basal cell carci-
noma in the Netherlands. Acta Derm Venereol 2011; 91: 24–30.
2. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous 
cell carcinoma in the Netherlands: increased incidence rates, but 
stable relative survival and mortality 1989–2008. Eur J Cancer 
2012; 48: 2046–2053.
3. Waalboer-Spuij R, Hollestein LM, Timman R, van de Poll-Franse 
LV, Nijsten TE. Development and validation of the Basal and 
Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire. 
Acta Derm Venereol 2018; 98: 234–239.
4. Husson O, Mols F, van de Poll-Franse LV. The relation between 
information provision and health-related quality of life, anxiety 
and depression among cancer survivors: a systematic review. 
Ann Oncol 2011; 22: 761–772.
5. Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de 
Poll-Franse LV. Illness perceptions in cancer survivors: what is the 
role of information provision? Psychooncol 2013; 22: 490–498.
6. van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, 
Roukema JA, Aaronson NK, et al. The Patient Reported Outcomes 
Following Initial treatment and Long term Evaluation of Survi-
vorship registry: scope, rationale and design of an infrastructure 
for the study of physical and psychosocial outcomes in cancer 
survivorship cohorts. Eur J Cancer 2011; 47: 2188–2194.
7. Arraras JI, Greimel E, Sezer O, Chie WC, Bergenmar M, Costantini 
A, et al. An international validation study of the EORTC QLQ-
INFO25 questionnaire: an instrument to assess the information 
given to cancer patients. Eur J Cancer 2010; 46: 2726–2738.
8. Aaronson NK, Ahmedzai S, Bergman B, et al. The European 
Organization for Research and Treatment of Cancer QLQ-C30: a 
quality-of-life instrument for use in international clinical trials in 
oncology. J Natl Cancer Inst 1993; 85: 365–376.
9. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The Self-
Administered Comorbidity Questionnaire: a new method to assess 
comorbidity for clinical and health services research. Arthritis 
Rheum 2003; 49: 156–163.
10. Glickman ME, Rao SR, Schultz MR. False discovery rate control 
is a recommended alternative to Bonferroni-type adjustments in 
health studies. J Clin Epidemiol 2014; 67: 850–857.
11. Quinten C, Coens C, Ghislain I, et al. The effects of age on health-
related quality of life in cancer populations: A pooled analysis of 
randomized controlled trials using the European Organisation for 
Research and Treatment of Cancer (EORTC) QLQ-C30 involving 
6024 cancer patients. Eur J Cancer 2015; 51: 2808–2819.
12. Sim JA, Shin JS, Park SM, Chang YJ, Shin A, Noh DY, et al. As-
sociation between information provision and decisional conflict 
in cancer patients. Ann Oncol 2015; 26: 1974–1980.1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3226
